74034-56-3CCCCC[C@H](O)/C=C/[C@H]1CC2CC(C2)[C@@H]1C/C=C\CCCC(=O)OZIWNJZLXPXFNGN-GXTQQWMXSA-N74034-56-3203.6 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]
200.4 Ų [M-H]-
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
개요Carbocyclic thromboxane A2 (CTA2) is a stable analog of TXA2. CTA2 is a potent coronary vasoconstrictor and is effective at concentrations as low as 1 nM in cat coronary arteries. Unlike other vascular TP receptor agonists, CTA2 is a potent inhibitor of prostanoid-induced platelet aggregation. It inhibits arachidonic acid-induced aggregation with an IC50 value of 4-5 μM. CTA2 also exhibits selective and dose-dependent inhibition of TXB2 synthesis in rabbit platelets at concentrations between 1 and 100 μM.
용도Carbocyclic Thromboxane A2 is a stable analog of TXA2 which inhibits thromboxane-mediated vasoconstriction platelet aggregation. Also, it converts the thromboxane synthase (TXAS) heme cofactor to its 5-coordinate.
불러오는 중…
불러오는 중…
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…